Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Oncology Letters|August 20, 2019
Expression of the immune checkpoint receptor TIGIT in seminomaAndrea Hinsch, Niclas C Blessin, Ronald Simon, et al.
Disease Markers|February 9, 2019
Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and CancerNiclas C Blessin, Ronald Simon, Martina Kluth, et al.
Cancer Medicine|January 2, 2020
Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patientsFranziska Büscheck, Mariam Sulimankhil, Nathaniel Melling, et al.
Pathology|August 15, 2025
High-level STING expression in tumour and inflammatory cells is linked to microsatellite instability and favourable tumour parameters in a cohort of over 1,900 colorectal cancer patientsElena Bady, Julia Ebner, Tim Mandelkow, et al.
Molecular Cancer Research : MCR|March 28, 2023
BLEACH&STAIN 15-marker Multiplexed Imaging in 3,098 Human Carcinomas Reveals Six Major PD-L1-driven Immune Phenotypes with Distinct Spatial OrchestrationElena Bady, Katharina Möller, Tim Mandelkow, et al.
BMC Cancer|December 6, 2018
Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphomaWenchao Li, Niclas C Blessin, Ronald Simon, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 29, 2022
Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligenceDavid Dum, Tjark L C Henke, Tim Mandelkow, et al.
Oncology Letters|October 16, 2019
Upregulation of SPDEF is associated with poor prognosis in prostate cancerJan Meiners, Katharina Schulz, Katharina Möller, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 7, 2020
Prevalence of CD8+ cytotoxic lymphocytes in human neoplasmsNiclas C Blessin, Patrick Spriestersbach, Wenchao Li, et al.
Cancer Biomarkers : Section a of Disease Markers|January 23, 2023
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samplesKatharina Möller, Madeleine Knöll, Elena Bady, et al.
Pageof 3